Artificial Intelligence Antios Therapeutics | Innovative Therapies for Viral Diseases


Enterprise, Biotechnology, Pharmaceuticals, Health Care, Therapeutics, Drug Discovery, Viral Diseases Atlanta, GA, United States

Antios Therapeutics

Artificial Intelligence


Antios Therapeutics | Innovative Therapies for Viral Diseases

Antios Therapeutics

Biotechnology, Pharmaceuticals, Health Care, Therapeutics, Drug Discovery, Viral Diseases


Atlanta, GA, United States

Antios Therapeutics is a clinical-stage biopharmaceutical company devoted to developing innovative therapies for viral diseases. With an experienced and proven leadership team, the company is focused on the development of its lead oral drug candidate for potentially curative treatment of HBV infections.

Our lead therapeutic candidate, ATI-2173, is a first-in-class Active Site Polymerase Inhibitor Nucleotide (ASPIN) that is in clinical development as the backbone of an oral, once-daily potential curative therapy for Hepatitis B Virus. To date, we have completed extensive pre-clinical work, as well as Phase 1 studies in both healthy volunteers and HBV-infected individuals. Antios Therapeutics was founded by Abel De La Rosa, Douglas Mayers, and Idean Marvasty.

 

B2B

26 to 50

Series B

$125.4 M

Scaling Up

2018

 
 

Healthcare
Biotechnology
Pharmaceuticals

N/A

Increase Efficiency

 
 

Production

Yes

Active

 
 

N/A


Biotechnology

Biotechnology

Drug Discovery

Drug Discovery


N/A

 

   Software


N/A


N/A

 
 

13

1

$96M

Company was founded 2018 and it took almost 3 years (Apr 2021) to raise first external round

 
 

Date

Round

$ Raised

Investors

04/12/2021

Series B

$96M

Soleus Capital, Sixty Degree Capital, RA Capital Management, Pontifax, Lumira Ventures, LifeSci Venture Partners, Granite Point Capital, Domain Associates, CAM Capital, Amzak Health Investors, Altium Capital, Aisling Capital, Adage Capital Management

Date : 04/12/2021

Round: Series B

$ Raised: $96M

Investors: Soleus Capital, Sixty Degree Capital, RA Capital Management, Pontifax, Lumira Ventures, LifeSci Venture Partners, Granite Point Capital, Domain Associates, CAM Capital, Amzak Health Investors, Altium Capital, Aisling Capital, Adage Capital Management

 

Investors

Interested in researching Antios Therapeutics?

We have plenty of data and we can help. Our deal sourcing platform can help you perform more research about Antios Therapeutics

Request a Demo - Deal Souring Platform

 
Greg Mayes


Greg Mayes
President and CEO

Idean M.


Idean M.
Co-founder

Tamra Adams


Tamra Adams
Chief Financial Officer

Douglas Mayers


Douglas Mayers
Chief Medical Officer

 
 

Potential Customers

Interested in what they do or partnership?

Learn more about how they work

Schedule a Call w/ Antios Therapeutics